World Intellectual Property Organization

CGTN: China emphasizes education, sci-tech, talent in modernization drive

Retrieved on: 
Wednesday, October 19, 2022
Time, National Congress of the Chinese Communist Party, World Intellectual Property Organization, Chinese Academy of Engineering, Research, Communist party, History, Technology, R, Global Innovation through Science and Technology initiative, University of the Chinese Academy of Sciences, CPC, CGTN, Innovation, Congress, List, WIPO, Ministry, National Congress, Creative industries, Tutoring, Education, Engineering, Science, Xi

Titled "Invigorating China Through Science and Education," the strategy was unveiled in 1995 and has been enriched with the infusion of new insights contained in a series of policies rolled out since then.

Key Points: 
  • Titled "Invigorating China Through Science and Education," the strategy was unveiled in 1995 and has been enriched with the infusion of new insights contained in a series of policies rolled out since then.
  • "Education, science and technology, and human resources are the foundational and strategic pillars for building a modern socialist country in all respects," Xi said.
  • China rose to 11th on the Global Innovation Index 2022, up from 12th last year, according to the World Intellectual Property Organization (WIPO) last month.
  • In 2021, there were 18.44 million full-time teachers at all levels and in all types of schools nationwide, an increase of 26.2 percent over 2012.

Steakholder Foods Files Provisional Patent Application for Improved Fat Differentiation Process

Retrieved on: 
Thursday, October 6, 2022
Method, United Nations Sustainable Development Group, U.S. Securities and Exchange Commission, Time, NESS, United Nations Global Compact, Carbon footprint, B cell, Annual report, NASDAQ, MITC, Food security, Research, Security (finance), Invention, Technology, Adipocyte, Water, Patent, WIPO, USPTO, Intellectual property, Nasdaq, World Intellectual Property Organization, Forward-looking statement, Patent Cooperation Treaty, Sustainable Development Goals, 3D printing

NESS ZIONA, Israel, Oct. 6, 2022 /PRNewswire/ -- Steakholder Foods Ltd. (NASDAQ: STKH), (formerly MeaTech 3D: $MITC), an international deep-tech cultured meat company, is pleased to announce that it has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO), regarding methods and systems for adipocytes differentiation. 

Key Points: 
  • The patent application details a new and improved process for differentiating stem cells into fat (increasing cultivated fat yields from stem cells), which is more easily reproducible and cost-effective than current methods.
  • This patent filing is the latest step in Steakholder Foods' push to reduce global dependence on animal-derived components.
  • To date, Steakholder Foods' patent portfolio, fully owned by Steakholder Foods group companies, includes a granted patent and 15 patent applications.
  • Arik Kaufman, Steakholder Foods' Chief Executive Officer& Founder:"The filing of this provisional patent application represents another step forward in Steakholder Foods' ongoing mission to reduce the cost and complexity of cultured fat production, and strengthens our fully-owned patent portfolio.

Trade Secrets: Approaches to Protection of Undisclosed Information - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 4, 2022
Legal, Professional Services, Morrison & Foerster, American Intellectual Property Law Association, Guide, Information Age, Trade secret, World Intellectual Property Organization, Patent, Morrison, OECD, Technology, Silk, Public relations, Private investigator

Trade Secrets has been cited prominently in the first major trade secrets study by an international organization, the OECD's "Approaches to Protection of Undisclosed Information (Trade Secrets)."

Key Points: 
  • Trade Secrets has been cited prominently in the first major trade secrets study by an international organization, the OECD's "Approaches to Protection of Undisclosed Information (Trade Secrets)."
  • Fortunately, you can consult Trade Secrets is a comprehensive yet concise guide to this complex field.
  • You'll find detailed explanations of internal policies, information protection plans, and negotiation strategies you can adopt to avoid disputes.
  • Trade Secrets has been cited prominently in the first major trade secrets study by an international organization, the OECD's "Approaches to Protection of Undisclosed Information (Trade Secrets)."

Tryp Therapeutics Announces Publication of International PCT Patent Application for the Intravenous Administration of Psilocin and Psilocybin

Retrieved on: 
Monday, October 3, 2022
Psilocybin, PTSD, GLOBE, Tic disorder, Phrase, News, Risk, Binge eating disorder, Psychotherapy, PCT, THE, Liver, CSE, Pain, Â, Patent, World Intellectual Property Organization, WIPO, University, Therapy, Fibromyalgia, Safety, Chronic pain, IP, ID, Patient, IV, THIS, OCD, Depression, Pharmaceutical industry, Risk management, Operation Web Tryp, Company

KELOWNA, British Columbia, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced that the World Intellectual Property Organization (WIPO) published their international patent application (PCT/IB2022/052347) covering the intravenous administration of psilocybin and psilocin. The PCT application, titled “Improved Methods For The Use of Psychedelics” expands and strengthens the IP related to the Company’s development of TRP-8803, an IV formulation of psilocin, which will be administered in conjunction with psychotherapy.

Key Points: 
  • Psilocybin is a pro-drug which needs to be converted to psilocin, the active molecule that crosses the blood brain barrier and induces the psychedelic state.
  • These factors contribute to variable blood levels of psilocin, which can be either too low or too high.
  • Conversely, should the patient experience a side effect, the clinician can terminate administration of the drug, an option not available with oral administration.
  • Orally administered psychedelics have been widely introduced for use in treating depression, PTSD, OCD and other conditions, including by Tryp Therapeutics and its TRP-8802 programs.

Akin Gump Expands World-Class Public Law and Policy Practice to Europe

Retrieved on: 
Wednesday, September 28, 2022
Gump, Policy, Chambers, Publication, World Health Organization, Organization, Intellectual property, Public policy, Climate change, IP, PLP, Government, Organic, Private sector, Goal, World, World Trade Organization, World Intellectual Property Organization, International law, Congress, Lawyer, Accounting, Public relations, Management

WASHINGTON and GENEVA, Sept. 28, 2022 /PRNewswire/ -- Akin Gump welcomes Jan Walter as a senior policy advisor to the firm's Washington, D.C.-based public law and policy (PLP) practice. Based in Geneva, Jan is the first member of the PLP group located outside the United States, a strategic expansion of the U.S. team's globally recognized lobbying and advocacy services to organizations with business interests outside of the U.S.

Key Points: 
  • Addition of international policy advisor Jan Walter in Geneva extends the reach of Akin Gump's global, multidisciplinary public law and policy, regulatory and international trade practices
    WASHINGTON and GENEVA, Sept. 28, 2022 /PRNewswire/ -- Akin Gump welcomes Jan Walter as a senior policy advisor to the firm's Washington, D.C.-based public law and policy (PLP) practice.
  • PLP practice co-head Brian Pomper commented, "We are very pleased to welcome Jan to our public law and policy practice.
  • Akin Gump's bipartisan public law and policy practice comprises more than 70 lawyers and other professionals, including former members of Congress and other lawyers with considerable experience in government service, who practice exclusively on legislative, policy and regulatory matters.
  • Akin Gump Strauss Hauer & Feld LLP is a leading international law firm with more than 900 lawyers and advisors in offices throughout the United States, Europe, Asia and the Middle East.

International Patent Protection of SixFix® Deformity Analysis & Correction Software

Retrieved on: 
Monday, September 26, 2022
Intellectual property, Patent, World Intellectual Property Organization, Canadian Intellectual Property Office, China National Intellectual Property Administration, AMDT, WIPO

COLLIERVILLE, Tenn., Sept. 26, 2022 /PRNewswire/ -- AMDT Holdings, Inc. of Collierville, Tennessee is pleased to announce that it has recently filed an international patent application with the World Intellectual Property Organization (WIPO) for the proprietary image registration process incorporated in the company's SixFixDeformity Analysis & Correction Software.

Key Points: 
  • COLLIERVILLE, Tenn., Sept. 26, 2022 /PRNewswire/ -- AMDT Holdings, Inc. of Collierville, Tennessee is pleased to announce that it has recently filed an international patent application with the World Intellectual Property Organization (WIPO) for the proprietary image registration process incorporated in the company's SixFixDeformity Analysis & Correction Software.
  • AMDT Holdings will continue to aggressively add to its robust portfolio of patents and pending U.S. and foreign patent applications to provide further protection for its SixFix Deformity Analysis & Correction Software and all of the company's continually developing external fixation technologies.
  • AMDT Holdings currently has over 65 patents and pending patent applications in the United States, Europe, Australia, Brazil, Canada, Japan, China, and WIPO covering the many novel and unique design aspects of its SixFixCircular Fixation System, SixFix Deformity Analysis & Correction Software, and Mini-Rail Fixator System.
  • Patents directed to the SixFix Circular Fixation System have been recently issued by the China National Intellectual Property Administration and the Australian Patent Office.

Lighthouse Capital CEO: Long China 2.0，New Opportunities Requiring New Capabilities

Retrieved on: 
Friday, September 23, 2022
Fund, Marina Bay Sands, Value-added service, D, Policy, Leo, Population, Hong Kong Stock Exchange, Lighthouse, Growth, Industry, Environment, Attention, Investment, GDP, Economic development, CEO, Internet, Technology, Logic, United States dollar, Ecosystem, Robotics, Industrialisation, Research, Multimedia, World Intellectual Property Organization, Renewable energy, Retail, Security (finance), Risk management

Leo Zheng, the founder and CEO of Lighthouse Capital, was invited to share his observations on the current investment environmentandopportunities in China.

Key Points: 
  • Leo Zheng, the founder and CEO of Lighthouse Capital, was invited to share his observations on the current investment environmentandopportunities in China.
  • The transformation of economic and industrial structure also gives birth to new opportunities in China, and according to Leo, there is reason to believe that China is ready to make good use of them.
  • Lighthouse Capital, with a global perspective, is exactly what a leading boutique investment bank in China should be like.
  • Having a good leading position in China enables us to see good opportunities earlier and seize good assets.

Georgia Set to Celebrate Intellectual Property Month in October for the Fifth Consecutive Year

Retrieved on: 
Thursday, September 15, 2022
Intellectual property, Fox Theatre (Atlanta), University, Under Secretary of Commerce for Intellectual Property, Celebration, Corporation, Law, The arts, Knowledge, Annual general meeting, Learning, IP, Georgia State University College of Law, United States Patent and Trademark Office, Patent, Technology, Ecosystem, Commerce, Conference, Awareness, GIPA, World Intellectual Property Organization, University college, Tutoring, Cable television

ATLANTA, Sept. 15, 2022 /PRNewswire-PRWeb/ -- The Georgia Intellectual Property Alliance (GIPA) is pleased to announce that on August 23, 2022, Governor Kemp signed a proclamation once again declaring that October will be Intellectual Property (IP) Month in Georgia. The proclamation is a recognition of the significant role that IP plays in Georgia's economy, encouraging investment in knowledge and innovation to move society forward and contribute to Georgia's thriving technology and creative media industries. Governor Kemp's declaration helps build awareness of IP across the state of Georgia and supports the ongoing efforts of GIPA and its constituents to improve access to and the functioning of the IP ecosystem for the benefit of all Georgia residents.

Key Points: 
  • ATLANTA, Sept. 15, 2022 /PRNewswire-PRWeb/ -- The Georgia Intellectual Property Alliance (GIPA) is pleased to announce that on August 23, 2022, Governor Kemp signed a proclamation once again declaring that October will be Intellectual Property (IP) Month in Georgia.
  • In honor of IP Month, GIPA will feature numerous events to highlight IP throughout the month of October.
  • Other events through IP Month include:
    CIP CUP (October 3) The 13th annual charity golf tournament at Laurel Springs Golf Club, Suwanee, Georgia, that benefits Georgia Lawyers for the Arts and GIPA.
  • The Georgia Intellectual Property Alliance (GIPA), a 501(c)(3) nonprofit founded in 2018, is empowering intellectual property to advance society through the creation of a model intellectual property (IP) ecosystem that is accessible to all.

Bang Energy® Shuts Down Illegal Car Wrap Scammers, Protects Consumers From Fraud

Retrieved on: 
Tuesday, September 6, 2022
University, CEO, Florida State University, FBI, College, Bang (beverage), Baylor University, World Intellectual Property Organization, Crime, CSO, Florida International University, University of Memphis, University of Southern Maine, GLOBE, VPX, Instagram, Sports nutrition, FAQ, Communication, News, University of South Alabama, WIPO, UCLA, Taste, College of New Jersey, Social media, Dietary supplement, Redline, Sport

Since the decision, the website domain has been transferred to Bang Energy and shut down, which will make the car wrapping scam less likely to occur through this website.

Key Points: 
  • Since the decision, the website domain has been transferred to Bang Energy and shut down, which will make the car wrapping scam less likely to occur through this website.
  • The illegal scam involved the development and registration of www.bangenergyadverts.com, a website (which is no longer active) that mimicked Bang Energy intellectual property and trademarks to trick consumers into transferring money in hopes of receiving weekly payments for advertising Bang Energy on their personal vehicles with car wrap materials.
  • Bang Energy continues to warn consumers against false promotions and scams, including text, email and direct message offers.
  • Now one of the top three energy drink brands in the U.S., Bang Energy/VPX Sports premium quality products include keto-friendly Meltdown, Quash, Vooz and Redline in addition to energy drink favorite, Bang Energy.

Cybin Inc. Reports First Quarter Financial Results and Recent Business Highlights

Retrieved on: 
Monday, August 8, 2022
Biotechnology, Mental Health, Health, Pharmaceutical, Clinical Trials, U.S. Securities and Exchange Commission, Risk, NEO, Trial of the century, Patent, Inc., Knowledge, Research, Patient, News, Food, Disease, MDD, Industry, Flow, DMT, Safety, Kernel, Nature, Metabolism, Pharmacokinetics, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Neuropharmacology, United Kingdom, Forward-looking statement, Growth, EDGAR, Engineering, Therapy, COVID-19, Acquisition, Excretion, Anxiety, Drug development, Health Canada, Time, United States Patent and Trademark Office, Organization, FDA, NYSE, IP, Lists of diseases, Psilocybin, Plasma, Calendar, Company, View, Central nervous system, NYSE American, World Intellectual Property Organization, Pharmaceutical industry, Online gambling, Risk management, Absorption

Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing Psychedelics to TherapeuticsTM, today reported unaudited financial results for its first quarter ended June 30, 2022 and recent business highlights.

Key Points: 
  • Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing Psychedelics to TherapeuticsTM, today reported unaudited financial results for its first quarter ended June 30, 2022 and recent business highlights.
  • Recent Business and Pipeline Highlights:
    Initiated enrollment for its first-in-human Phase 1/2a trial of CYB003 in major depressive disorder (MDD).
  • Based on preclinical data, CYB003 achieved less variability in plasma levels, faster onset of action, and shorter duration of effect.
  • If Cybin cannot obtain the approvals or research necessary to commercialize its business, it may have a material adverse effect on Cybins performance and operations.